Grady, John
Parikh, Neehar D.
Article History
Accepted: 1 January 2024
First Online: 17 January 2024
Declarations
:
: Neehar Parikh serves as a consultant for Exact Sciences, Eli Lilly, Freenome, and has served on advisory boards of Genentech, Eisai, Exelixis, Wako/Fujifilm and has received research funding from Bayer, Target Pharmasolutions, Exact Sciences, and Glycotest. John Grady has no disclosures.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).